<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25387512</article-id>
      <article-id pub-id-type="pmc">4230676</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20143232</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>What Is Your Diagnosis?</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Case for diagnosis<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Boza</surname>
            <given-names>Juliana Catucci</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dorn</surname>
            <given-names>Timotio Volnei</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Oliveira</surname>
            <given-names>Fabiana Bazanella</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bakos</surname>
            <given-names>Renato Marchiori</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <aff id="aff01"><label>1</label> Universidade Federal do Rio Grande do Sul (UFRGS) - Porto Alegre
(RS), Brazil.</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c01"><italic>MAILING ADDRESS:</italic> Juliana Catucci Boza, Rua Ramiro Barcelos, 2350,
Santa Cec&#xED;lia, 90035-903 Porto Alegre - RS, Brazil. E-mail:
<email>juliana_boza@yahoo.com.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Nov-Dec</season>
        <year>2014</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2014</year>
      </pub-date>
      <volume>89</volume>
      <issue>6</issue>
      <fpage>999</fpage>
      <lpage>1001</lpage>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>10</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>3</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>The Osler-Weber-Rendu syndrome or Hereditary Hemorrhagic Telangiectasia (HHT) is a
systemic fibrovascular dysplasia characterized by defects in the elastic and vascular
walls of blood vessels, making them varicose and prone to disruptions. Lesions occur
in different organs and can lead to hemorrhage in the lungs, digestive tract and
brain. We describe the case of a patient with cutaneous manifestations and severe
impairment of the digestive tract. It is important for the dermatologist to recognize
this syndrome, since the cutaneous lesions may play a key role in diagnosis.</p>
      </abstract>
      <kwd-group>
        <kwd>Diagnosis</kwd>
        <kwd>Epistaxis</kwd>
        <kwd>Telangiectasia, hereditary hemorrhagic</kwd>
        <kwd>Telangiectasis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>CASE REPORT</title>
      <p>A 73-year-old woman who was hospitalized for hematemesis had multiple, punctiform
telangiectasia lesions all over the integument since she was 40 years old. Lesions were
most prominent in the oral mucosa, on the tongue, hands and feet (<xref ref-type="fig" rid="f01">Figures 1</xref> and <xref ref-type="fig" rid="f02">2</xref>). She also
reported recurrent episodes of nasal and intestinal bleeding. The patient underwent
hysterectomy at age 39 due to menometrorrhagia. The son and grandson had similar skin
lesions.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Telangiectasia on the oral mucosa. Lesions are also observed on the face</p>
        </caption>
        <graphic xlink:href="abd-89-06-0999-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Telangiectasia on the foot sole</p>
        </caption>
        <graphic xlink:href="abd-89-06-0999-g02"/>
      </fig>
      <p>Complementary exams revealed 8.5 g/dL hemoglobin, 79 fl. mean corpuscular volume (MCV),
and 35&#xB5;g/L serum ferritin, which is consistent with iron deficiency anemia. An upper
endoscopy revealed angiectases (some were 3 mm in diameter, friable) in the fornix,
gastric body and second duodenal portion (<xref ref-type="fig" rid="f03">Figure
3</xref>). CT angiography of the chest and computed cranial tomography showed no
alterations.</p>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Upper endoscopy photos: Presence of multiple, friable, shiny telangiectasias in
the fornix and gastric body, and tiny angiectases in the second duodenal
portion</p>
        </caption>
        <graphic xlink:href="abd-89-06-0999-g03"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The Osler-Weber-Rendu syndrome or Hereditary Hemorrhagic Telangiectasia (HHT) is a
systemic fibrovascular dysplasia characterized by defects in the elastic and vascular
walls of blood vessels, making them varicose and prone to disruptions.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref></sup>
It is an underdiagnosed entity.<sup><xref rid="r03" ref-type="bibr">3</xref></sup></p>
      <p>HHC has autosomal dominant inheritance, and homozygosity is incompatible with life.
There are two subtypes: type 1 is related to a mutation in the endoglin gene (ENG,
chromosome 9q34.1) and pulmonary involvement; type 2 is related to a mutation in the
activin receptor-like kinase 1 gene (ACVRL 1, ALK1, chromosome 12q31.34), with a mild
phenotype and late onset.<sup><xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r04" ref-type="bibr">4</xref></sup>
These two mutations occur in 85% of cases. Both endoglin and ACVRL-1 are expressed in
the endothelium, and interfere with the growth-transformation factor &#x3B2;
(TGF-&#x3B2;).<sup><xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r05" ref-type="bibr">5</xref></sup> Mutations have
been described in the SMAD4 gene, also related to the TGF-&#x3B2;, in patients with juvenile
polyposis and HHT.<sup><xref rid="r05" ref-type="bibr">5</xref>,<xref rid="r06" ref-type="bibr">6</xref></sup> TGF-&#x3B2; is important in the differentiation and growth of
smooth muscle cells which form the walls of blood vessels. For this reason, its
reduction is related to the formation of fragile vessels.<sup><xref rid="r07" ref-type="bibr">7</xref></sup></p>
      <p>HHT is characterized by hemorrhagic phenomena and punctiform telangiectasia lesions
predominantly located on the face, lips, oral mucosa, hands and feet, with onset usually
in the third decade of life.<sup><xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r07" ref-type="bibr">7</xref></sup> The most common manifestation is
epistaxis (80-90% of cases) and it regularly precedes cutaneous manifestations.
Pulmonary involvement occurs in 30% of patients due to arteriovenous malformations,
causing dyspnea, fatigue, and cyanosis. Brain, liver, gastrointestinal and genitourinary
involvement may occur.<sup><xref rid="r08" ref-type="bibr">8</xref></sup></p>
      <p>The Cura&#xE7;ao diagnostic criteria are: (1) spontaneous, recurrent epistaxis; (2) multiple
telangiectases; (3) visceral lesions; (4) positive family history (three first-degree
relatives affected.</p>
      <p>Treatment is directed to the clinical manifestations of the condition. In the treatment
of epistaxis and digestive manifestations, endoscopic or surgical intervention may be
indicated.<sup><xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r08" ref-type="bibr">8</xref></sup> Bevacizumab, a monoclonal antibody that blocks the action
of VEGF (vascular endothelial growth factor), is being used in cases of epistaxis or
gastrointestinal bleeding.<sup><xref rid="r09" ref-type="bibr">9</xref></sup> The Nd YAG
and Pulsed Dye lasers have shown to be effective in the treatment of telangiectasias.
However, relapses can occur.<sup><xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>It is important to warn the patient about the possibility of bleeding and provide
pre-pregnancy counseling due to a greater risk of complications.<sup><xref rid="r11" ref-type="bibr">11</xref></sup> The case reported here reinforces the
importance of knowing this syndrome, which presents skin changes that are often subtle
but also decisive for the diagnosis of a condition with severe systemic involvement.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
      <fn fn-type="other">
        <p>How to cite this article: Boza JC, Dorn T, Oliveira FB, Bakos RM. Case for diagnosis.
Hereditary hemorrhagic telangiectasia. An Bras Dermatol. 2014;89(6):999-1001.</p>
      </fn>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p> Study conducted at the Dermatology Service of the Hospital de Clinicas de Porto
Alegre - Universidade Federal do Rio Grande do Sul (HCPA-UFRGS) - Porto Alegre (RS),
Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fuchizaki</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Miyamori</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kitagawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kaneko</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Hereditary Haemorrhagic Telangiectasia (Rendu-Osler-Weber
Disease)</article-title>
          <source>Lancet</source>
          <year>2003</year>
          <volume>362</volume>
          <fpage>1490</fpage>
          <lpage>1494</lpage>
          <pub-id pub-id-type="pmid">14602446</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Juares</surname>
              <given-names>AJC</given-names>
            </name>
            <name>
              <surname>Dell'Aringa</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Nardi</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Kobori</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>VLMGM</given-names>
            </name>
            <name>
              <surname>Filho</surname>
              <given-names>RMP</given-names>
            </name>
          </person-group>
          <article-title>Rendu-Osler-Weber Syndrome: case report and literature
review</article-title>
          <source>Rev Bras Otorrinolaringol</source>
          <year>2008</year>
          <volume>74</volume>
          <fpage>452</fpage>
          <lpage>457</lpage>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Albuquerque</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Terra</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Quinete</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Hereditary hemorrhagic telangiectasia: tranexamic acid for plantar
ulcer</article-title>
          <source>An Bras Dermatol</source>
          <year>2005</year>
          <volume>80</volume>
          <fpage>S373</fpage>
          <lpage>S375</lpage>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olitsky</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
          <article-title>Hereditary hemorrhagic telangiectasia: diagnosis and
management</article-title>
          <source>Am Fam Physician</source>
          <year>2010</year>
          <volume>82</volume>
          <fpage>785</fpage>
          <lpage>790</lpage>
          <pub-id pub-id-type="pmid">20879701</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>T&#xF8;rring</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Brusgaard</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ousager</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kjeldsen</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>National mutation study among Danish patients with hereditary
hemorrhagic telangiectasia</article-title>
          <source>Clin Genet</source>
          <year>2013</year>
          <pub-id pub-id-type="doi">10.1111/cge.12269</pub-id>
          <comment>[Epub ahead of print]</comment>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gallione</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Richards</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Letteboer</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Rushlow</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Prigoda</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Leedom</surname>
              <given-names>TP</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>SMAD4 mutations found in unselected HHT patients</article-title>
          <source>J Med Genet</source>
          <year>2006</year>
          <volume>43</volume>
          <fpage>793</fpage>
          <lpage>797</lpage>
          <pub-id pub-id-type="pmid">16613914</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goumans</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>ten Dijke</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>TGF-beta signaling in vascular biology and dysfunction</article-title>
          <source>Cell Res</source>
          <year>2009</year>
          <volume>19</volume>
          <fpage>116</fpage>
          <lpage>127</lpage>
          <pub-id pub-id-type="pmid">19114994</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McDonald</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bayrak-Toydemir</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pyeritz</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Hereditary hemorrhagic telangiectasia: an overview of diagnosis,
management, and pathogenesis</article-title>
          <source>Genet Med</source>
          <year>2011</year>
          <volume>13</volume>
          <fpage>607</fpage>
          <lpage>616</lpage>
          <pub-id pub-id-type="pmid">21546842</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dupuis-Girod</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ambrun</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Decullier</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Samson</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Roux</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fargeton</surname>
              <given-names>AE</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>ELLIPSE Study: A Phase 1 study evaluating the tolerance of bevacizumab
nasal spray in the treatment of epistaxis in hereditary hemorrhagic
telangiectasia</article-title>
          <source>MAbs</source>
          <year>2014</year>
          <volume>6</volume>
          <fpage>793</fpage>
          <lpage>798</lpage>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Halachmi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Israeli</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ben-Amitai</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lapidoth</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Treatment of the skin manifestations of hereditary hemorrhagic
telangiectasia with pulsed dye laser</article-title>
          <source>Lasers Med Sci</source>
          <year>2014</year>
          <volume>29</volume>
          <fpage>321</fpage>
          <lpage>324</lpage>
          <pub-id pub-id-type="pmid">23681198</pub-id>
        </element-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shovlin</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Sodhi</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lasjaunias</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Sheppard</surname>
              <given-names>MN</given-names>
            </name>
          </person-group>
          <article-title>Estimates of maternal risks of pregnancy for women with hereditary
haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): suggested approach for
obstetric services</article-title>
          <source>BJOG</source>
          <year>2008</year>
          <volume>115</volume>
          <fpage>1108</fpage>
          <lpage>1115</lpage>
          <pub-id pub-id-type="pmid">18518871</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
